Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × surufatinib × Sarcoma × Clear all

Phase

Status

Unknown 1 Terminated 1 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 11 Thoracic 4 Endocrine 3 Head & Neck 2 Breast 2 Sarcoma 1 Other solid neoplasm 1 NET 1

Conditions

Interventions

Doxorubicin 20 Radiotherapy 15 Cyclophosphamide 15 apatinib 14 Ifosfamide 12 anlotinib 11 Temozolomide 9 Imatinib Mesylate 9 Vincristine 8 camrelizumab 7 Surgical Procedures, Operative 7 Drug Therapy 7 Methotrexate 6 Neoadjuvant Therapy 5 Dactinomycin 5 fludarabine phosphate 4 Paclitaxel 4 Etoposide 4 Docetaxel 4 Carboplatin 4 toripalimab 3 pembrolizumab 3 Trabectedin 3 Topotecan 3 Surveys and Questionnaires 3 Radiation Dose Hypofractionation 3 Nivolumab 3 Melphalan 3 Laparoscopy 3 Irinotecan 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05106777 2023-04-12

Surufatinib in Patients With Osteosarcoma and Soft Tissue Sarcoma

Sun Yat-sen University

Phase 2 Unknown

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡